Preparation and primary bioevaluation of 99mtc-labeled-1-thio-β-dglucose as melanoma targeting agent

Current Radiopharmaceuticals

Volumn 4, Issue 4, 2011, Pages 355-360

  Castelli, Romina ^a   Fernándeza, Marcelo ^a   Porcal, Williams ^b   Gambini, Juan Pablo ^c   Alonso, Omar ^c   Chabalgoity, Alejandro ^d   Moreno, María ^d   Cabral, Pablo ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d Universidad de la Republica Instituto de Higiene   (Uruguay)

Author keywords

1 thio D glucose; Cell uptake; Melanoma; Radiopharmaceutical; Tumor imaging

Indexed keywords

1 THIO BETA D GLUCOSE; GLUCOSE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TARGETING; EARLY DIAGNOSIS; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 80052203480     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011104040355     Document Type: Article

References (28)

1. Miao, Y.; Whitener, D.; Feng, W.; Owen, N.K.; Chen, J.; Quinn, T.P. Evaluation of the Human Melanoma Targeting Properties of Radiolabeled Melanocyte Stimulating Hormone Peptide Analogues. Bioconjugate Chem., 2003, 14, 1177-1184.
2. Oliveria, S.A.; Saraiya, M.; Geller, A.C.; Heneghan, M.K.; Jorgensen, C. Sun exposure and risk of melanoma. Arch. Dis. Child., 2006, 91, 131-138.
3. Zbytek, B.; Carlson, J.A.; Granese, J.; Ross, J.; Mihm, M.C.; Slominski, A. Current concepts of metastasis in melanoma. Expert. Rev. Dermatol., 2008, 3, 569-585.
4. Wahl, L. Targeting Glucose Transporters for Tumor Imaging: Sweet Idea, Sour Result. J. Nucl. Med., 1996, 37, 1038-1041.
5. Brown, R.S.; Wahl, R.L. Overexpression of Glut-1 Glucose Transporter in Human Breast Cancer. An Immunohistochemical Study. Cancer, 1993, 72, 2979-2985.
6. Younes, M.; Brown, R.W.; Stephenson, M.; Gondo, M.; Cagle, B.P.T. Overexpression of Glut1 and Glut3 in Stage I Nonsmall Cell Lung Carcinoma Is Associated with Poor Survival. Cancer, 1997, 80, 1046-1051.
7. Parente, P.; Coli, A.; Massi, G.; Mangoni, A.; Fabrizi, M.M.; Bigotti, G. Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions. J. Exp. Clin. Cancer. Res., 2008, 27, 1-6.
8. Blasberg, R.G. Molecular Imaging and Cancer. Mol. Cancer. Ther., 2003, 2,335-343.
9. Imam, S.K. Molecular Nuclear Imaging: The Radiopharmaceuticals. Cancer. Biother. Radiopharm., 2005, 20, 163-172.
10. Belhocine, T.Z.; Scott, A.M.; Even-Sapir, E.; Urbain, J.L.; Essner, R. Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma. J. Nucl. Med., 2006, 47, 957-967.
11. Ho Shona, I.A.; Chungc, D.K.V.; Sawd, R.P.M.; Thompsond, J.F. Imaging in cutaneous melanoma. Nucl. Med. Commun., 2008, 29, 847-876.
12. Wahl, R.L.; Hutchins, G.D.; Buchsbaum, D.J.; Liebert, M.; Grossman, H.B.; Fisher, S. 18F-2-D eoxy-2-Fluoro-D-Glucose Uptake Into Human Tumor Xenogrcrfts. Feasibility Studies for Cancer Imaging With Positron-Emission Tomography. Cancer, 1991, 67, 1544-1550.
13. Gritters, L.S.; Francis, I.R.; Zasadny, K.R.; Wahl, R.L. Initial Assessment of Positron Emission Tomography Using 2-Fluorine-18- Fluoro-2-Deoxy-D-Glucose in the Imaging of Malignant Melanoma. J. Nucl. Med., 1993, 34, 1420-1427.
14. Delbeke, D. Oncological Applications of FDG PET Imaging: Brain Tumors, Colorectal Cancer Lymphoma and Melanoma. J. Nucl. Med., 1999, 40, 591-603.
15. Xiong, Q.; Chen, Y. Deoxyglucose Compounds Labeled with Isotopes Different from 18-Fluoride: Is There a Future in Clinical Practice? Cancer. Biother. Radiopharm., 2008, 23, 376-381.
16. Ametamey, S.M.; Honer, M.; Schubiger, P.A. Molecular Imaging with PET. Chem. Rev. 2008, 108, 1501-1516.
17. Yang, D.J.; Kim, C.G.; Schechter, N.R.; Azhdarinia, A.; Yu, D.F.; Oh, C.S.; Bryant, J.L.; Won, J.J.; Kim, E.E.; Podoloff, D.A. Imaging with 99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents. Radiology., 2003, 226, 465-473.
18. Abram, U.; Alberto, R. Technetium and Rhenium-Coordination Chemistry and Nuclear Medical Applications. J. Braz. Chem. Soc., 2006, 17, 1486-1500.
19. Technetium-99m radiopharmaceuticals: status and trends. IAEA radioisotopes and radiopharmaceuticals. Series n° 1. International Atomic Energy Agency, Vienna, 2009.
20. Schibli1, R.; Schubiger, P.A. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med., 2002, 29, 1529-1542.
21. Meszaros, L.K.; Dose, A.; Biagini, S.C.G.; Blower, P.J. Hydrazinonicotinic acid (HYNIC)-Coordination chemistry and applications in radiopharmaceutical chemistry. Inorg. Chim. Acta., 2010, 363, 1059-1069.
22. Chen, X.; Li, L.; Liu, F.; Liu, B. Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. Bioorg. Med. Chem. Lett., 2006, 16, 5503-5506.
23. Branco de Barros, L.A.; Cardoso, V.N.; das Graças Mota, L.; Amaral Leite, E.; de Oliveira, M.C.; Alves, R.J. A novel D-glucose derivative radiolabeled with technetium-99m: Synthesis, biodistribution studies and scintigraphic images in an experimental model of Ehrlich tumor. Bioorg. Med. Chem. Lett., 2010, 20, 2478-2480.
24. Brasileiro, C.B.; da Fonseca Pacheco, C.M.; Queiroz-Junior, C.M.; de Lima, C.F.; da Silva, J.B.; Ribeiro de Campos, T.P. 99mTclabeled-1-thio-β-d-glucose as a new tool to temporo mandibular joint inflammatory disorders diagnosis. Appl. Radiat. Isotopes., 2010, 68, 2261-2267.
25. [Gambini, J.P.; Cabral, P.; Alonso, O.; Savio, E.; Figueroa, S.D.; Zhang, X.; Ma, L.; Deutscher, S.L.; Quinnd, T.P. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. Nucl. Med. Biol., 2010, in press.
26. Oh, S.J.; Ryu, J.S.; Yoon, E.J.; Bae, M.S.; Choi, S.J.; Park, K.B.; Moon, D.H. 99mTc-labeled 1-thio-β-D-glucose as a new tumorseeking agent: Synthesis and tumor cell uptake assay. Appl. Radiat. Isotopes., 2006, 64, 207-215.
27. Welling, M.M.; Alberto, R. Performance of a 99mTc-labelled 1- thio-b-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG. Nucl. Med. Commun., 2010, 31, 239-248.
28. Motale, M.A. Preparation, quality control and stability of 99mTcsparafloxacin complex, a novel agent for detecting sites of infection. J. Label Compd. Radiopharm, 2009, 52, 415-418.